ERYP.PA - ERYTECH Pharma S.A.

Paris - Paris Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue4,4473,3644,1382,929
Cost of Revenue----
Gross Profit4,4473,3644,1382,929
Operating Expenses
Research Development33,46825,46319,72010,776
Selling General and Administrative14,6008,7916,8087,736
Non Recurring----
Others----
Total Operating Expenses48,06834,25426,52818,512
Operating Income or Loss-43,621-30,890-22,390-15,583
Income from Continuing Operations
Total Other Income/Expenses Net5,399-2,643487567
Earnings Before Interest and Taxes-43,621-30,890-22,390-15,583
Interest Expense-9-15-4-30
Income Before Tax-38,222-33,533-21,903-15,016
Income Tax Expense2-310-3
Minority Interest----
Net Income From Continuing Ops-38,224-33,530-21,913-15,013
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-38,224-33,530-21,913-15,013
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-38,224-33,530-21,913-15,013